Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-24-007038)

Filing Details

Accession Number:: 0001562180-24-007038
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-01 16:17:45
Reporting Period:: 2024-09-30

Accepted Time:: 2024-10-01 16:17:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822791	Clene Inc.	CLNN	Pharmaceutical Preparations (2834)	852828339

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835427	Mark Mortenson	6550 South Millrock Drive Suite G50 Salt Lake City UT 84121	Chief Science Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-30	20,512	$4.75	28,949	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to buy)	Acquisiton	2024-09-30	20,512	$0.13	20,512	$4.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,512	2024-10-01	2029-10-01	No	4	A	Direct

Footnotes

On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's previously owned 168,759 shares of common being reduced to 8,437 shares of common stock.